Academic detailing, described as “university or non-commercial-based educational outreach”, is crucial for enhancing patient care and reducing health care costs within the realm of medication therapy. With a goal of improving the prescribing of targeted drugs, academic detailing typically involves face-to-face education of prescribers by trained health care professionals (typically pharmacists, physicians, or nurses) who work to make sure that prescribing is according to medical evidence from randomized controlled trials. One of the main elements of non-commercial or university-based detailing programs is that they don't have any financial links to the pharmaceutical industry. Academic analysis has been studied for over 25 years and has confirmed compelling at developing the prescription of targeted medications about 5% from baseline. Though it's primarily wont to affect prescribing, it's also wont to educate providers regarding other non-drug interventions, like health care screening guidelines.
As organizations develop and refine their academic detailing programs to enhance patient care, our experiences at Atrius Health have shown us that academic detailing must be an endless process of evaluation and collaboration for adapting to changes in today’s healthcare environment. Our Academic Detailing Service (ADS) for the Atrius Health Clinical Pharmacy program has emerged over the past several years through the appraisal of its impact, encouragement of internal feedback, and by working with others within the field, including the National Resource Center for tutorial Detailing (NaRCAD).
When we began the clinical pharmacy ADS program in 2011, our clinical pharmacists detailed clinicians in individually scheduled appointments or in larger groups during department meetings. Our objective was to satisfy all general medicine and family practice prescribers once per fiscal quarter to debate cost-effective prescribing and clinical quality. Documentation of our ADS meetings consisted of checking off an inventory of the clinicians we detailed each quarter.
At that point, there was no formal training for our clinical pharmacists on the way to conduct a detailing meeting. Our method of making content for visits soon resulted during a large menu of topics so varied that every quarter detailing became unwieldy and too broadly focused. While our documentation gave us a general sense of the number of clinicians detailed, it didn't tell us anything about the standard of our interactions.